Catalyst Wire Dossier Catalyst Wire Dossier

Deferasirox dispersible tablet

deferasirox · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Deferasirox dispersible tablet, covering 2021-10-04 to 2021-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet [Phase 2]

See pricing